Shanghai Henlius Biotech, Inc. is a global biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of biologic medicines. Established in 2010 and head... Shanghai Henlius Biotech, Inc. is a global biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of biologic medicines. Established in 2010 and headquartered in Shanghai, the company operates with a vision to provide high-quality, affordable, and innovative biopharmaceutical therapies to patients worldwide. Its primary areas of focus include oncology, autoimmune diseases, and ophthalmic diseases, supporting a broad product portfolio spanning monoclonal antibodies, antibody-drug conjugates, fusion proteins, and small molecules. Henlius has launched multiple products in major and emerging markets, including first-in-class and biosimilar therapies such as anti-PD-1 and anti-HER2 monoclonal antibodies. The company’s commitment to global regulatory standards is reflected in its manufacturing facilities, which are certified by authorities in China, the EU, and the United States. With a substantial research pipeline of approximately 50 molecules and a strong emphasis on immuno-oncology and combination therapies, Henlius plays a significant role in advancing access to cutting-edge treatments and shaping the landscape of biotechnology innovation both domestically and internationally.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Shanghai Henlius Biotech is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Shanghai Henlius Biotech is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Shanghai Henlius Biotech's data?

Start your 30-day free trial to request a data review for Shanghai Henlius Biotech.

Start Free Trial

Legal Center Contact Us